Decreased monocytic HLA-DR in patients with sepsis: Prediction of diagnosis, severity and prognosis

Juanjuan Cui; Wen Cai; Li Zhang; Yueyuan Wu; Yan Huang; Weifeng Zhao

doi:10.1016/j.clinbiochem.2024.110851

Decreased monocytic HLA-DR in patients with sepsis: Prediction of diagnosis, severity and prognosis

Clin Biochem. 2024 Nov 14:110851. doi: 10.1016/j.clinbiochem.2024.110851. Online ahead of print.

Authors

Juanjuan Cui¹, Wen Cai², Li Zhang³, Yueyuan Wu⁴, Yan Huang⁵, Weifeng Zhao⁶

Affiliations

¹ Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: [email protected].
² Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: [email protected].
³ Center of Clinical Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: [email protected].
⁴ Center of Clinical Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: [email protected].
⁵ Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: [email protected].
⁶ Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: [email protected].

PMID: 39550023
DOI: 10.1016/j.clinbiochem.2024.110851

Abstract

Objective: Sepsis is characterized by high incidence and mortality rates, making early recognition and risk stratification critical for preventing delayed treatment and overtreatment. This study investigated the potential of monocytic (m) HLA-DR as a diagnostic and prognostic biomarker of sepsis.

Methods: In this prospective study, we collected blood in EDTA-anticoagulated tubes within 48 h from patients diagnosed with sepsis or infection and analyzed the percentage of mHLA-DR in peripheral blood mononuclear cells, C-reactive protein, and procalcitonin within 2 h of collection. We gathered clinical and laboratory data, including sex, age, and comorbidities, calculated the number of dysfunctional organs and sequential organ failure assessment (SOFA) score, and recorded the survival status of patients with sepsis on the 30th day after admission.

Results: mHLA-DR levels were lower in patients with sepsis (median 46.60 [interquartile range 23.86-66.51]%) than infection (75.44 [52.13-91.50]%). mHLA-DR could distinguish sepsis from infection with an area under the curve (AUC) of 0.724 (95 %CI 0.624-0.824). Decreased mHLA-DR levels have been found in septic patients with shock or secondary infections. mHLA-DR expression decreased with an increasing number of dysfunctional organs and higher SOFA score. In 30-day non-survivors, mHLA-DR levels were 26.94 (12.06-44.45)%, significantly lower than in survivors (55.20 [24.83-72.37]%). mHLA-DR predicted sepsis prognosis with an AUC of 0.750 (95 %CI 0.623-0.877). When the cut-off value was <52.29 %, the sensitivity and specificity of mHLA-DR for prognosis were 100 % and 52.83 %, respectively. The 30-day survival rate of septic patients with mHLA-DR ≥ 52.29 % was 6.798 (95 %CI 2.075-22.27) times higher than that of patients with mHLA-DR < 52.29 %.

Conclusion: mHLA-DR negatively correlates with the severity of sepsis and could be used as a diagnostic and prognostic biomarker for sepsis.

Keywords: Diagnosis; Infection; Monocytic HLA-DR; Prognosis; Sepsis; Severity.